Recommendations for the treatment of multiple sclerosis with disease-modifying drugs during the COVID-19 pandemic

The novel coronavirus 2019 (COVID-19) and the subsequent pandemic present a challenge to neurologists treating patients with multiple sclerosis (MS) worldwide. Many national professional bodies have responded rapidly by issuing guidelines for the COVID-19 pandemic, primarily focused on MS disease-m...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	R. Kizlaitienė, N. Giedraitienė, I. Sereikė, J. Liutkienė, L. Leščinskienė, G. Kaubrys
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Vilnius University Press 2020-06-01
Saila:	Neurologijos seminarai
Gaiak:	COVID-19 pandemic multiple sclerosis disease-modifying therapies
Sarrera elektronikoa:	https://www.journals.vu.lt/neurologijos_seminarai/article/view/27741
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!